• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Quality assurance in the urologist's practice. Erectile dysfunction as an example of a multicenter approach to documenting treatment results].

作者信息

Jünemann K-P, Cassens S, Lippert H, Burkart M

机构信息

Klinik für Urologie und Kinderurologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel.

出版信息

Urologe A. 2005 Jul;44(7):785-93. doi: 10.1007/s00120-005-0837-1.

DOI:10.1007/s00120-005-0837-1
PMID:15905987
Abstract

Of 517 urologist practices approached, 93% participated in a pilot study on the quality of care in the treatment of erectile dysfunction (ED). Treatment modalities and satisfaction were documented for 10,750 ED patients in 2002-at a time when vardenafil and tadalafil had not yet been officially approved. Psychological factors (55%), BPH (42%), and hypertension (33%) were given as the most prevalent ED risk factors; 82% of the patients received sildenafil, 20% apomorphine, 12% yohimbine, and 10% intracavernous alprostadil. Of the patients, 81% were satisfied or very satisfied with one of the treatment options offered and 85% and more were satisfied or very satisfied with sildenafil's onset of action, duration of action, efficacy, and tolerability. Of the physicians, 97% rated the opportunity to compare their own treatment results with other urologists' results as important or very important.

摘要

相似文献

1
[Quality assurance in the urologist's practice. Erectile dysfunction as an example of a multicenter approach to documenting treatment results].
Urologe A. 2005 Jul;44(7):785-93. doi: 10.1007/s00120-005-0837-1.
2
[Management of erectile dysfunction after radical prostatectomy. Urologists' assessment vs patient survey responses].[根治性前列腺切除术后勃起功能障碍的管理。泌尿外科医生的评估与患者调查反馈]
Urologe A. 2006 Mar;45(3):336, 338-42. doi: 10.1007/s00120-005-0972-8.
3
Does management of erectile dysfunction after radical prostatectomy meet patients' expectations? Results of a national survey (REPAIR) by the French Urological Association.根治性前列腺切除术后勃起功能障碍的管理是否符合患者期望?法国泌尿外科学会全国性调查(REPAIR)结果
J Sex Med. 2008 Mar;5(3):693-704. doi: 10.1111/j.1743-6109.2007.00743.x. Epub 2008 Jan 11.
4
Treatment satisfaction with sildenafil in a Canadian real-life setting. A 6-month prospective observational study of primary care practices.加拿大实际应用中对西地那非的治疗满意度。一项针对基层医疗实践的为期6个月的前瞻性观察研究。
J Sex Med. 2007 Sep;4(5):1414-21. doi: 10.1111/j.1743-6109.2007.00555.x. Epub 2007 Jul 21.
5
Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.西地那非、海绵体内注射前列腺素E1及阴茎植入手术治疗泌尿外科勃起功能障碍患者的满意度及勃起功能比较
J Urol. 2003 Jul;170(1):159-63. doi: 10.1097/01.ju.0000072524.82345.6d.
6
Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.按需服用他达拉非(希爱力)治疗男性勃起功能障碍的疗效及治疗满意度
Eur Urol. 2004 Sep;46(3):362-9; discussion 369. doi: 10.1016/j.eururo.2004.04.026.
7
Urologist practice patterns in the management of premature ejaculation: a nationwide survey.泌尿外科医生治疗早泄的实践模式:一项全国性调查。
J Sex Med. 2008 Jan;5(1):199-205. doi: 10.1111/j.1743-6109.2007.00638.x. Epub 2007 Oct 25.
8
Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.英国全科医疗中良性前列腺增生、勃起功能障碍或同时患有良性前列腺增生和勃起功能障碍患者的特征及治疗模式:一项回顾性观察研究。
Int J Clin Pract. 2015 Aug;69(8):853-62. doi: 10.1111/ijcp.12657. Epub 2015 May 25.
9
Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.在三级医疗学术中心评估他达拉非与安慰剂对勃起功能障碍患者的疗效、安全性及治疗满意度。
Urology. 2005 Feb;65(2):353-9. doi: 10.1016/j.urology.2004.09.056.
10
Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment.阴茎海绵体内注射前列腺素E1治疗勃起功能障碍:长期治疗的患者满意度及性生活质量
J Sex Med. 2007 Mar;4(2):426-31. doi: 10.1111/j.1743-6109.2006.00260.x.

本文引用的文献

1
[Legal ballast or useful instrument for urologic practice?].[法律约束还是泌尿外科实践的有用工具?]
Aktuelle Urol. 2004 Sep;35(5):389-90. doi: 10.1055/s-2004-834368.
2
[Quality management--should it remain as is or be changed? On the medical practice of a "learning organization"].质量管理——应维持现状还是进行变革?关于“学习型组织”的医疗实践
Urologe A. 2004 Sep;43(9):1171-3. doi: 10.1007/s00120-004-0684-5.
3
Lower urinary tract symptoms (LUTS) and sexual function in both sexes.男女的下尿路症状(LUTS)与性功能
Eur Urol. 2004 Aug;46(2):229-34. doi: 10.1016/j.eururo.2004.04.005.
4
[Erectile dysfunction. Epidemiology, physiology, etiology, diagnosis and therapy].[勃起功能障碍。流行病学、生理学、病因学、诊断与治疗]
Urologe A. 2004 Feb;43(2):197-207; quiz 208-9. doi: 10.1007/s00120-003-0527-9.
5
Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate.从前列腺素E(1)海绵体内注射疗法转换为口服枸橼酸西地那非的勃起功能障碍患者的治疗满意度
Int J Impot Res. 2003 Dec;15(6):444-9. doi: 10.1038/sj.ijir.3901049.
6
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).下尿路症状与男性性功能障碍:老年男性多国调查(MSAM-7)
Eur Urol. 2003 Dec;44(6):637-49. doi: 10.1016/j.eururo.2003.08.015.
7
Oral sildenafil (Viagra) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital.口服西地那非(万艾可)治疗男性勃起功能障碍:在一家英国地区综合医院就诊的未经筛选队列中的应用、疗效及安全性概况
BMC Urol. 2002 Apr 18;2:4. doi: 10.1186/1471-2490-2-4.
8
Guidelines on erectile dysfunction.勃起功能障碍指南。
Eur Urol. 2002 Jan;41(1):1-5. doi: 10.1016/s0302-2838(01)00008-2.
9
When an erection alone is not enough: biopsychosocial obstacles to lovemaking.当仅有勃起并不够时:性行为的生物心理社会障碍
Int J Impot Res. 2002 Feb;14 Suppl 1:S99-S104. doi: 10.1038/sj.ijir.3900799.
10
Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors.枸橼酸西地那非治疗伴有相关器质性风险因素人群勃起功能障碍的疗效与安全性。
J Androl. 2001 Sep-Oct;22(5):793-7.